Multiple media channels, both national and international, have echoed a study published by Robert E. Coleman (University of Sheffield) in the Lancet Oncology and which involved Roger Gomis (IRB Barcelona). The work allows early detection of patients who could benefit from zoledronic acid and those who should avoid it. Such early detection would thus accelerate the administration of the first preventive treatment for metastasis.
Link to JANO
Link to La Vanguardia
Link to EFE Futuro
Link to BioTech
Link to Medindia
Link to Medical Xpress
Link to ecancer
The projects address breast, lung, colon, prostate and melanoma cancer.
The newspaper “La Opinión de Zamora” has published an article devoted to breast cancer, one of the tumours most widely diagnosed in women in Spain and one of the most lethal.
The magazine Cambio 16 has wrote an article on the 20 projects that the "la Caixa" Foundation has awarded to promote excellence in the fight against diseases that have a big impact in the world. One of these projects is the "Metastasis Cell Fate Mapping" by Roger Gomis, ICREA researcher at IRB Barcelona, who will develop strategies to compensate for the effect of mutations that influence the progression of breast cancer in order to find new treatments.
